This inventor holds 40 USPTO granted patents and 2 published patent applications and 15 EPO patents, primarily in Carboxamide Derivatives. Top assignees: Sanofi-Aventis, Sanofi, Synthelabo. Active years: 1993-2014.
Location History:
- Bullion, FR (1999 - 2012)
- Antony, FR (2012)
- Paris, FR (1993 - 2013)
- Dannemois, FR (2008 - 2014)
Company Filing History:
18 out of 390 
17 out of 1,540 
3 out of 252 
Years Active: 1993-2014
Areas of Expertise:
Title: The Innovative Genius of Yannick Evanno
Introduction: Yannick Evanno, a prominent inventor from Dannemois, France, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a portfolio boasting 40 patents, Yannick's work has paved the way for advancements in therapeutic compounds and methodologies, demonstrating his expertise and dedication to innovation.
Latest Patents: Among Yannick Evanno's latest patents is the invention titled "N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives." This invention focuses on compounds of a specific general formula, where various components are defined for therapeutic applications. Additionally, another patent relates to compounds of a similar general formula, emphasizing methods for their preparation and therapeutic use.
Career Highlights: Yannick's career includes positions at notable companies such as Sanofi and Sanofi-Aventis. His experience in these organizations allowed him to leverage his knowledge and skills in drug development, contributing to the creation of innovative pharmaceutical solutions.
Collaborations: Throughout his career, Yannick has worked alongside esteemed colleagues, including Laurent Dubois and Andre Malanda. These collaborations have fostered a dynamic exchange of ideas and expertise, enhancing the quality of his inventions and patents.
Conclusion: Yannick Evanno stands as a testament to innovation in the pharmaceutical industry. With a rich patent portfolio and valuable collaborations, he continues to make strides in the development of therapeutic compounds. His contributions not only reflect his intellectual prowess but also his commitment to improving healthcare through innovative solutions.